TEXAS INSTITUTE FOR SURGERY AT PRES — History
CCN 450889 | 3-year financial timeline | COVID resilience: 70/100
🛡️ Public data only — no PHI permitted on this instance.
$76M
Latest Revenue (FY2022)
+9.5%
Revenue CAGR (3yr)
24.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $64M | $72M | $76M | +5.9% | +9.5% |
| Operating Expenses | $51M | $55M | $58M | +4.2% | +6.6% |
| Operating Margin | 20.4% | 23.4% | 24.6% | +5.3% | +10.0% |
| Net Income | $13M | $17M | $19M | +11.4% | +20.5% |
| Licensed Beds | 9 | 9 | 9 | +0.0% | +0.0% |
| Total Patient Days | 945 | 920 | 681 | -26.0% | -15.1% |
| Medicare Day % | 50% | 51% | 56% | +11.1% | +6.3% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 70/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +20.0% ($64M → $76M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+9.5%
This Hospital
+7.6%
State Avg
Latest Margin
24.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $83M | 26.8% |
| FY2024 (proj) | $89M | 28.9% |
| FY2025 (proj) | $96M | 31.0% |